InVivo Therapeutics Holdings Co (NVIVQ)

NVIVQ Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	8.58	16.35	19.03	19.49	6.61	16.66
Cash & Cash Equivalents	8.58	16.35	19.03	19.49	6.61	16.66
Cash Growth	-19.02%	-14.08%	-2.37%	195.08%	-60.36%	25.57%
Other Current Assets	0.94	1.25	0.11	0.16	0.18	0.46
Total Current Assets	9.53	17.6	19.14	19.66	6.78	17.13
Property, Plant & Equipment	0.01	1.07	1.36	1.01	1.28	0.1
Long-Term Investments	0.05	0.15	0.15	0.11	0.11	0.11
Goodwill and Intangibles	0	0	0	0.01	0	0
Other Long-Term Assets	0	0	1.12	1.12	1.15	1.04
Total Long-Term Assets	0.06	1.22	2.63	2.25	2.54	1.25
Total Assets	9.58	18.82	21.77	21.91	9.33	18.38
Accounts Payable	0.12	0.62	0.61	0.48	0.94	0.82
Current Debt	0	0.4	0.36	0.33	0.29	0.1
Other Current Liabilities	0.54	1.41	1.65	1.16	1.43	1.29
Total Current Liabilities	0.67	2.42	2.61	1.97	2.66	2.21
Long-Term Debt	0	0.55	0.95	0.69	1.02	0
Other Long-Term Liabilities	0	0.1	0.09	0.06	0.06	0.06
Total Long-Term Liabilities	0	0.66	1.04	0.75	1.08	0.06
Total Liabilities	0.67	3.08	3.66	2.72	3.74	2.27
Total Debt	0	0.95	1.31	1.02	1.31	0.1
Debt Growth	-	-27.56%	28.43%	-22.37%	1214.00%	-88.26%
Retained Earnings	-255.59	-248.62	-238.13	-228.23	-219.16	-207.33
Shareholders' Equity	8.92	15.75	18.12	19.19	5.58	16.11
Net Cash / Debt	8.58	15.4	17.72	18.47	5.29	16.56
Net Cash / Debt Growth	-10.18%	-13.09%	-4.07%	249.07%	-68.05%	33.38%
Net Cash Per Share	2.76	10.02	13.39	66.90	394.51	2489.33
Working Capital	8.86	15.18	16.53	17.68	4.12	14.92
Book Value Per Share	2.87	10.25	13.69	69.49	416.21	2421.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).